1. Home
  2. BNGO vs BFRI Comparison

BNGO vs BFRI Comparison

Compare BNGO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.09

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$1.22

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNGO
BFRI
Founded
2003
1997
Country
United States
United States
Employees
N/A
94
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
13.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BNGO
BFRI
Price
$1.09
$1.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.00
$2.75
AVG Volume (30 Days)
97.1K
367.7K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
94.50
N/A
EPS
N/A
N/A
Revenue
$12,000,735.00
N/A
Revenue This Year
$14.99
$14.36
Revenue Next Year
$34.73
$16.98
P/E Ratio
N/A
N/A
Revenue Growth
26.26
N/A
52 Week Low
$1.06
$0.57
52 Week High
$5.50
$1.21

Technical Indicators

Market Signals
Indicator
BNGO
BFRI
Relative Strength Index (RSI) 38.81 61.66
Support Level $1.08 $0.71
Resistance Level $1.19 N/A
Average True Range (ATR) 0.03 0.06
MACD -0.01 0.00
Stochastic Oscillator 14.29 89.74

Price Performance

Historical Comparison
BNGO
BFRI

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: